Khor Y, Ng Y, Barnes H, Goh N, McDonald C, Holland A
Eur Respir Rev. 2020; 29(157).
PMID: 32759374
PMC: 9488716.
DOI: 10.1183/16000617.0158-2019.
Bandorski D, Alles J, Basten O, Bruck M
Med Klin (Munich). 2011; 105(12):952-8.
PMID: 21240597
DOI: 10.1007/s00063-010-1163-y.
Al-Khawari H, Athyal R, Al-Saeed O, Sada P, Al-Muthairi S, Al-Awadhi A
Ann Saudi Med. 2010; 30(2):129-33.
PMID: 20220262
PMC: 2855063.
DOI: 10.4103/0256-4947.60518.
Mapel D, Hunt W, Utton R, Baumgartner K, Samet J, Coultas D
Thorax. 1998; 53(6):469-76.
PMID: 9713446
PMC: 1745251.
DOI: 10.1136/thx.53.6.469.
Hubbard R, Johnston I, Coultas D, Britton J
Thorax. 1996; 51(7):711-6.
PMID: 8882078
PMC: 472494.
DOI: 10.1136/thx.51.7.711.
Accuracy of the typical computed tomographic appearances of fibrosing alveolitis.
Tung K, Wells A, Rubens M, Kirk J, du Bois R, Hansell D
Thorax. 1993; 48(4):334-8.
PMID: 8135910
PMC: 464428.
DOI: 10.1136/thx.48.4.334.
Prognosis of cryptogenic fibrosing alveolitis.
Tukiainen P, Taskinen E, HOLSTI P, Korhola O, Valle M
Thorax. 1983; 38(5):349-55.
PMID: 6879483
PMC: 459556.
DOI: 10.1136/thx.38.5.349.
Cryptogenic fibrosing alveolitis: pattern of disease in the lung.
WRIGHT P, Buxton-Thomas M, Kreel L, STEEL S
Thorax. 1984; 39(11):857-61.
PMID: 6505992
PMC: 459937.
DOI: 10.1136/thx.39.11.857.
Serum type III procollagen peptide concentration in cryptogenic fibrosing alveolitis and its clinical relevance.
Kirk J, Bateman E, Haslam P, Laurent G, TURNER-WARWICK M
Thorax. 1984; 39(10):726-32.
PMID: 6495240
PMC: 459910.
DOI: 10.1136/thx.39.10.726.
Cryptogenic fibrosing alveolitis: prediction of fibrogenic activity from immunohistochemical studies of collagen types in lung biopsy specimens.
Bateman E, TURNER-WARWICK M, Haslam P, Adelmann-Grill B
Thorax. 1983; 38(2):93-101.
PMID: 6344313
PMC: 459496.
DOI: 10.1136/thx.38.2.93.
Mortality in cases of asbestosis diagnosed by a pneumoconiosis medical panel.
Coutts I, GILSON J, KERR I, PARKES W, TURNER-WARWICK M
Thorax. 1987; 42(2):111-6.
PMID: 3433233
PMC: 460635.
DOI: 10.1136/thx.42.2.111.
Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis.
Johnson M, Kwan S, Snell N, Nunn A, Darbyshire J, TURNER-WARWICK M
Thorax. 1989; 44(4):280-8.
PMID: 2669218
PMC: 461792.
DOI: 10.1136/thx.44.4.280.
Idiopathic interstitial fibrosis.
Lambe D
Lung. 1990; 168 Suppl:993-7.
PMID: 2117220
DOI: 10.1007/BF02718237.
High resolution computed tomography as a predictor of lung histology in systemic sclerosis.
Wells A, Hansell D, Corrin B, Harrison N, Goldstraw P, Black C
Thorax. 1992; 47(9):738-42.
PMID: 1440471
PMC: 474812.
DOI: 10.1136/thx.47.9.738.
